How the Basel Area Life Sciences Supercluster supports commercial expansion in Europe

The Basel Area is widely recognized as a leading strategic hub in Switzerland for life sciences commercial success. While the area has long appealed to pharmaceutical and biotechnology companies executing research and development operations, it is now enticing innovative commercial-stage companies in these industries as well as medical devices, biotechnology, healthtech, and diagnostics – to name a few – for European expansion.

In a globalized market, a variety of U.S.-based life sciences companies have realized the strategic value of establishing a corporate presence on both sides of the Atlantic, through dual headquartering, incorporating a European headquarters, and/or expanding office locations. Once the cradle of scientific discovery, the Basel Area is home to industry giants like Novartis and Roche due to its high concentration of scientific expertise, access to capital, and geographic accessibility. Today, that strong foundation is supporting widespread innovative commercial growth as the region offers the optimal environment for a broad range of operational and commercial functions within the life sciences industry.

Associated with the inspiring tales of numerous Nobel Prize and Lasker Award recipients, Basel’s history set the stage for today’s vibrant ecosystem. Today, innovative life sciences companies are assessing  unique location-anchored opportunities that offer bright possibilities for future growth. The conditions that make the Basel Area so ripe for corporate expansion include a:

• Business-friendly operational environment, 
• Impressive, large talent pool, and
• Identity as a commercial European gateway.

For the companies and employees who are making the Basel Area home, they are successfully leveraging these three attributes to get ahead in a crowded market. 

For executives looking to expand their U.S.-based life sciences company into Europe, this article provides a holistic understanding of the opportunities in the Basel Area for commercial expansion. It also reveals the unique benefits and incentives currently offered to companies of all sizes looking to expand in the region. Finally, executives will hear from industry players about why they chose the Basel Area as the location for their expanding business.

Switzerland, and the Basel Area specifically, houses a pro-business government that fully supports life sciences growth opportunities. This supportive ecosystem is a huge draw for life sciences companies looking to expand in the continent. Thanks, in part, to its stable economic and political environment, Switzerland is known for its highly productive business climate and strong operational performance. These qualities make the Basel Area ripe for investing in innovation and growth, with capital, confidence and efficiency top of mind.

Attractive financials

From launch to expansion of U.S. operations, growing companies benefit from the Basel Area’s favorable tax laws. Although the corporate tax rate is already among the lowest in the country (13% for companies with less than $750 million in global revenue and 15% for companies exceeding that level), additional incentives exist that can lower this figure to just 10.6%. 

In addition, the Canton of Basel-Stadt launched an exciting program in 2025, which pays for up to 25% of eligible R&D personnel costs for technical and scientific roles. This exciting fund is just another example of how growing companies benefit from a business environment that is designed to accelerate innovation and scale.

Supportive government

The supportive ecosystem facilitated by a transparent government yields strategic value, according to Kirsten Detrick, Basel Area Business & Innovation’s Chief Representative in the U.S. “Business conditions in the region support scientific endeavors and translate those successes into business advantage,” she reports.

Local labor laws further support flexible hiring of talent in this employer-friendly life sciences ecosystem. Switzerland’s labor framework, both stable and predictable, is not defined by the detailed regulations on workplace structure that are widespread across other countries and in the U.S. The country boasts a strong tradition of social partnership between employers and employees, with negotiable working conditions, low union disruption, and liberal hiring and termination practices. 

The cooperative approach, which largely benefits employers, allows expanding companies to scale and manage their workforce with efficiency – another plus to operating in the Basel Area’s predictable environment.

Scientific growth in the Basel Area is not a recent trend; in fact, traditions of stunning innovation, cutting-edge discovery, and collaborative growth are deep rooted in the region. The rise of pharmaceutical giants was built on the foundation of scientific scholars and medical pioneers over many centuries, demonstrating an established and enduring culture of innovation. Today’s impressive regional talent pool is a direct result of this environment, which forms the foundation of success for life science businesses of every type to succeed.

With three times more life sciences talent in commercial, medical affairs, market access, supply chain, tech ops, and regulatory roles compared to any other Swiss region, the Basel Area boasts top-notch experts in every launch-relevant function. With more than 33,000 life sciences professionals, finding talent in the Basel Area is a friction-free process.

The world has taken notice. In fact, Switzerland has been #1 in the IMD World Talent Ranking for 10 consecutive years. In sum, the Basel Area is populated with industry professionals who have “been there, done that,” says Detrick, noting that experienced talent can ease the common concerns of European expansion.

A cross-functional team of experienced talent is the key to successful expansion efforts abroad. Theo Rowley, Former Director of Talent Acquisition at Moderna, notes its significance in the history of life sciences growth in the region.

Importantly, experienced employees like those in the Basel Area possess a collaborative, cross-functional mindset. This diversity of functional expertise and background means that unlike in other Swiss cantons without this array of experiences, the Basel Area is a hub for formal and informal exchanges regarding investment, research, drug development, and commercialization strategies.

For example, visit a café in Basel, Detrick says, and chances are, the person to the left is a scientist developing an exciting new asset, the person to the right is a venture capitalist looking to invest, and the people at the next table are debating the best way to generate European access and reimbursement for a soon-to-be-launched drug. This collaborative environment, rich with life sciences professionals, means residents are often striking up conversations that have important consequences on growth.

Finally, the amazing quality of life in the Basel Area has a huge impact on talent retention. A survey by the Federal Statistical Office (FSO) has revealed that once internationals have settled in Switzerland, very few want to leave. A whopping 63% of non-Swiss say they never want to leave the country.

As the Basel Area has developed and grown over the past decade, it is now widely recognized as a key life sciences commercial gateway in Europe. The city itself boasts a “borderless” central location where Switzerland, France, and Germany intersect. 

While many of the Basel Area’s inhabitants and professionals are bilingual or multilingual, the life sciences ecosystem operates primarily in English, a benefit that U.S.-based executives and employees enjoy.

The Basel Area is also conveniently well connected to Europe’s large capital cities, offering two-hour (or less) access through direct flights on various airline carriers with convenient connections to the downtown Basel Area available via bus, train, tram, or car.

Furthermore, the EuroAirport Basel–Mulhouse–Freiburg operates a dedicated “cool+connect” cold-chain facility at the airport specifically designed for pharmaceutical shipments, handling temperature-controlled containers directly on airport grounds and maintaining validated cold-chain conditions for products in the +2°C to +8°C range. Swissport (the world’s largest provider of airport ground handling and air cargo services) specifically cites Basel as a major European gateway for life-science cargo.

A high density of industry experts and life sciences resources support various stages of the commercial lifecycle in the Basel Area. Within and around the city, contract development and manufacturing organizations (CDMOs), supply chain experts, world-class academic research institutions, biotech marketing professionals, and pharmaceutical industry consultants are primed to support commercial growth decision-making. 

Importantly, the Basel Area is primed for corporate expansion. Office availability is nearly three times that of other Swiss locations, with flexible, future-ready workspaces available at some of Switzerland’s most affordable rents. While Europe as a whole faces a lab space shortage, the Basel Area Life Sciences Supercluster’s state-of-the-art R&D facilities are move-in ready and purpose-built for life sciences by world-renowned architects. This includes flexible and ample space offerings, from small- to medium-sized options up to 10,000 m2 for hundreds of (or more) employees.

Entrance into the European market through a world-leading biopharma ecosystem like the Basel Area has never been more accessible. As an industry epicenter, the region is the perfect target destination for expanding life sciences companies. A rich talent base of life sciences professionals facilitates high-quality hiring for the expansion of cross-functional teams. The government’s consistent support of the pro-business culture allows companies to grow and thrive. And its optimal location – interconnected and stacked with supportive infrastructure – has solidified the Basel Area as a key European life sciences commercial gateway. In sum, the region boasts a business-friendly environment in an optimal location that’s rich with resources and talent, giving expanding innovators the opportunity to capture a sustainable, commercial advantage.